Authors:
Bailey, RD
Hart, RG
Benavente, O
Pearce, LA
Citation: Rd. Bailey et al., Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage, NEUROLOGY, 56(6), 2001, pp. 773-777
Authors:
Hart, RG
Pearce, LA
Miller, VT
Anderson, DC
Rothrock, JF
Albers, GW
Nasco, E
Citation: Rg. Hart et al., Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: Frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies, CEREB DIS, 10(1), 2000, pp. 39-43
Citation: Rg. Hart et al., Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy, J AM COL C, 35(1), 2000, pp. 183-187
Authors:
Dolezal, O
Pearce, LA
Lawrence, LJ
McCoy, AJ
Hudson, PJ
Kortt, AA
Citation: O. Dolezal et al., ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V-L to V-H orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers, PROTEIN ENG, 13(8), 2000, pp. 565-574
Citation: Rg. Hart et La. Pearce, Antithrombotic therapy to prevent stroke in patients with atrial fibrillation - In response, ANN INT MED, 132(10), 2000, pp. 841-842
Citation: La. Pearce et al., Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation, AM J MED, 109(1), 2000, pp. 45-51
Citation: Rg. Hart et al., Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis, CEREB DIS, 9(4), 1999, pp. 215-217
Authors:
Lind, SE
Pearce, LA
Feinberg, WM
Bovill, EG
Citation: Se. Lind et al., Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities, BL COAG FIB, 10(5), 1999, pp. 215-227
Authors:
Goldman, ME
Pearce, LA
Hart, RG
Zabalgoitia, M
Asinger, RW
Safford, R
Halperin, JL
Citation: Me. Goldman et al., Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study), J AM S ECHO, 12(12), 1999, pp. 1080-1087
Authors:
Asinger, RW
Koehler, J
Pearce, LA
Zabalgoitia, M
Blackshear, JL
Fenster, PE
Strauss, R
Hess, D
Pennock, GD
Rothbart, RM
Halperin, JL
Citation: Rw. Asinger et al., Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study), J AM S ECHO, 12(12), 1999, pp. 1088-1096
Authors:
Hart, RG
Pearce, LA
McBride, R
Rothbart, RM
Asinger, RW
Citation: Rg. Hart et al., Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials, STROKE, 30(6), 1999, pp. 1223-1229
Authors:
Feinberg, WM
Pearce, LA
Hart, RG
Cushman, M
Cornell, ES
Lip, GYH
Bovill, EG
Citation: Wm. Feinberg et al., Markers of thrombin and platelet activity in patients with atrial fibrillation - Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study, STROKE, 30(12), 1999, pp. 2547-2553
Authors:
Hart, RG
Benavente, O
McBride, R
Pearce, LA
Citation: Rg. Hart et al., Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis, ANN INT MED, 131(7), 1999, pp. 492
Authors:
Blackshear, JL
Zabalgoitia, M
Pennock, G
Fenster, P
Strauss, R
Halperin, J
Asinger, R
Pearce, LA
Citation: Jl. Blackshear et al., Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation, AM J CARD, 83(3), 1999, pp. 453
Authors:
Dittrich, HC
Pearce, LA
Asinger, RW
McBride, R
Webel, R
Zabalgoitia, M
Pennock, GD
Safford, RE
Rothbart, RM
Halperin, JL
Hart, RG
Citation: Hc. Dittrich et al., Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study, AM HEART J, 137(3), 1999, pp. 494-499